Requested symbol wasn't found

U.S. Markets close in 4 hrs 10 mins

(CBST)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
0.000.00 (0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.00
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investor's Business Daily2 years ago

    Superbugs Turn Big Pharma, Gov't Focus To Antibiotics

    Late last month, the Obama administration rolled out a five-point plan to combat drug-resistant bacteria, which it said causes 2 million infections and 23,000 deaths in the U.S. alone every year. A report ...

  • GuruFocus.com2 years ago

    Mario Gabelli's Top 5 Stock Picks

    Mario Gabelli (Trades, Portfolio) is the founder of GAMCO Investors, a firm with $49.9 billion in assets under management across a range of funds.

  • Market Realist2 years ago

    Farallon Capital Starts New Position in Cubist Pharmaceuticals

    In December, the FDA approved Zerbaxa, Cubist's antibiotic that combats urinary tract infections and intra-abdominal infections in adults around the world.